Phathom Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
Phathom Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Florham Park
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PHAT
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001783183
EIN
82-4151574

Board of directors

Chief executives

Steven L. Basta · President and CEO
Since April 2025
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

216.9% a year in revenue

20% of the scoring weight is on file. Figures cover December 2024 – December 2025.

Terrie Curran · President and Chief Executive
Until April 2025 · Former

Director election results

Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 6 other boards. 5 are in the same sector.

Network of Phathom Pharmaceuticals Inc.'s board connections Agilent Technologies Inc. Agilent Technologies I... AnaptysBio Inc. AnaptysBio Inc. Arcutis Biotherapeutics Inc. Arcutis Biotherapeutic... Attovia Therapeutics Inc. Attovia Therapeutics I... NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Co... Yarrow Bioscience Inc. Yarrow Bioscience Inc. Heidi Fields Heidi Fields James N. Topper James N. Topper Steven L. Basta Steven L. Basta Terrie Curran Terrie Curran Phathom Pharmaceuticals In...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 6, 2026 Narula Sanjeev Officer (Chief Financial & Bus. Officer) Shares withheld for tax −13,485 $6.78 $91,428
Sep 3, 2026 Breedlove Robert Charles Officer (Principal Accounting Officer) Shares withheld for tax −460 $9.05 $4,163
Jul 14, 2026 Breedlove Robert Charles Officer (Principal Accounting Officer) Shares withheld for tax −1,555 $11.04 $17,167
May 22, 2026 Asit Parikh Director Gift −28,000 — —
May 22, 2026 Asit Parikh Director Gift +28,000 — —
May 20, 2026 Asit Parikh Director Option exercise +17,500 $4.95 $86,625
May 19, 2026 Asit Parikh Director Grant or award +24,122 — —
May 19, 2026 James N. Topper Director, 10% owner Grant or award +24,122 — —
May 19, 2026 Mark Stenhouse Director Grant or award +24,122 — —
May 19, 2026 Heidi Fields Director Grant or award +24,122 — —
May 19, 2026 Michael F. Cola Director Grant or award +24,122 — —
May 19, 2026 Frank Karbe Director Grant or award +24,122 — —
May 19, 2026 Theodore R. Schroeder Director Grant or award +24,122 — —
Mar 10, 2026 Asit Parikh Director Gift −40,000 — —
Mar 10, 2026 Asit Parikh Director Gift +40,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Phathom Pharmaceuticals Inc.

Who is the CEO of Phathom Pharmaceuticals Inc.?

Steven L. Basta has been Phathom Pharmaceuticals Inc.'s President and CEO since April 2025.

How many directors are on Phathom Pharmaceuticals Inc.'s board?

Phathom Pharmaceuticals Inc.'s board has 10 directors: Asit Parikh, David A. Socks, Frank Karbe, Heidi Fields, James N. Topper, Mark Stenhouse, Michael F. Cola, Steven L. Basta, Terrie Curran and Theodore R. Schroeder.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="phathom-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.